Venetoclax-Rituximab Treatment of Relapsed/Refractory CLL During the COVID-19 Pandemic: A Real-Life Experience in Selected Central-Southern Italian Regions

Detalles Bibliográficos
Autores principales: Molica, Stefano, Sportoletti, Paolo, Di Renzo, Nicola, Musto, Pellegrino, Pane, Fabrizio, Di Raimondo, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2021
Materias:
Scientific Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265379/
https://www.ncbi.nlm.nih.gov/pubmed/34276911
http://dx.doi.org/10.4084/MJHID.2021.042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265379/
https://www.ncbi.nlm.nih.gov/pubmed/34276911
http://dx.doi.org/10.4084/MJHID.2021.042

Ejemplares similares